A detailed history of Wellington Management Group LLP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 4,094,449 shares of VRTX stock, worth $1.93 Billion. This represents 0.35% of its overall portfolio holdings.

Number of Shares
4,094,449
Previous 4,558,233 10.17%
Holding current value
$1.93 Billion
Previous $1.91 Billion 0.72%
% of portfolio
0.35%
Previous 0.35%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$392.81 - $485.53 $182 Million - $225 Million
-463,784 Reduced 10.17%
4,094,449 $1.92 Billion
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $1.86 Billion - $2.03 Billion
4,558,233 New
4,558,233 $1.91 Billion
Q4 2023

Feb 12, 2024

BUY
$343.0 - $410.68 $1.79 Billion - $2.15 Billion
5,228,538 New
5,228,538 $2.13 Billion
Q3 2023

Nov 14, 2023

SELL
$338.18 - $362.46 $347 Million - $372 Million
-1,027,043 Reduced 13.6%
6,525,851 $2.27 Billion
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $11.1 Million - $12.4 Million
35,346 Added 0.47%
7,552,894 $2.66 Billion
Q1 2023

May 12, 2023

BUY
$283.23 - $323.1 $195 Million - $223 Million
689,965 Added 10.11%
7,517,548 $2.37 Billion
Q4 2022

Feb 13, 2023

SELL
$285.76 - $321.48 $343 Million - $386 Million
-1,201,759 Reduced 14.97%
6,827,583 $1.97 Billion
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $56.5 Million - $63 Million
-206,297 Reduced 2.5%
8,029,342 $2.32 Billion
Q2 2022

Aug 15, 2022

BUY
$234.96 - $292.55 $42.7 Million - $53.2 Million
181,929 Added 2.26%
8,235,639 $2.32 Billion
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $340 Million - $401 Million
1,535,255 Added 23.55%
8,053,710 $2.1 Billion
Q4 2021

Feb 11, 2022

BUY
$177.01 - $223.45 $75.6 Million - $95.5 Million
427,366 Added 7.02%
6,518,455 $1.43 Billion
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $400 Million - $448 Million
-2,204,600 Reduced 26.58%
6,091,089 $1.1 Billion
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $39.2 Million - $46.3 Million
209,325 Added 2.59%
8,295,689 $1.67 Billion
Q1 2021

May 17, 2021

SELL
$207.02 - $241.31 $232 Million - $270 Million
-1,120,147 Reduced 12.17%
8,086,364 $1.74 Billion
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $625 Million - $834 Million
3,020,047 Added 48.82%
9,206,511 $2.18 Billion
Q3 2020

Nov 16, 2020

SELL
$255.65 - $303.1 $70.4 Million - $83.5 Million
-275,346 Reduced 4.26%
6,186,464 $1.68 Billion
Q2 2020

Aug 14, 2020

SELL
$225.48 - $295.8 $259 Million - $340 Million
-1,149,958 Reduced 15.11%
6,461,810 $1.88 Billion
Q1 2020

May 14, 2020

BUY
$199.77 - $247.81 $35.1 Million - $43.5 Million
175,609 Added 2.36%
7,611,768 $1.81 Billion
Q4 2019

Feb 11, 2020

BUY
$166.71 - $223.91 $1.24 Billion - $1.67 Billion
7,436,159 New
7,436,159 $1.63 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.